Why the study?
Does percutaneous mitral balloon valvuloplasty improve outcomes compared to mitral valvular surgery in patients with symptomatic mitral stenosis?
Does percutaneous mitral balloon valvuloplasty improve outcomes compared to mitral valvular surgery in patients with symptomatic mitral stenosis?
Percutaneous mitral balloon valvuloplasty is a highly successful procedure with comparable outcomes to surgery for symptomatic mitral stenosis, though it carries small risks of death, regurgitation, and embolization.
Answers are grounded in this paper and cite their sources.
May support balloon valvuloplasty in experienced centers; leaves open need for randomized trials versus surgery.
Almost all mitral stenosis (MS) is rheumatic in etiology. The patient with MS who is symptomatic despite medical therapy should undergo percutaneous mitral balloon valvuloplasty or mitral valvular surgery (commissurotomy or replacement). The choice of procedure is determined by patient preference and the echocardiographic morphologic features of the valvular and subvalvular apparati. With balloon valvuloplasty, the rate of success is > 90%. At institutions where operators are experienced with balloon valvuloplasty and open surgical commissurotomy, their acute and long-term results are comparable. Balloon valvuloplasty occasionally is associated with complications, including death in 0 to 1%, moderate or severe valvular regurgitation in 3 to 5%, and systemic embolization in 1 to 3%.
No takes yet. Share an insight, caveat, or question.
Mayes et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: